Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Convatec Group PLC AGM Information 2017

Apr 4, 2017

4959_rns_2017-04-04_a0497e46-8cf9-4896-8280-153b072c2ffc.html

AGM Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4388B

ConvaTec Group PLC

04 April 2017

Notice of Annual General Meeting

READING, UNITED KINGDOM (4 April 2017) - ConvaTec Group Plc ("ConvaTec" or the "Group"), a leading global medical products and technologies company, has today published on the Group's website its Notice of Annual General Meeting (the "Notice of AGM").  The Notice of AGM is available at www.convatecgroup.com.

In compliance with Listing Rule 9.6.1, a copy of the Notice of AGM will also shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM.

The Annual General Meeting will be held at 11am on Thursday 11th May 2017 at Victoria Hall, Reading Town Hall, Blagrave Street, Reading RG1 1QH. Full details about the resolutions to be proposed and important information about the meeting are included within the Notice of AGM.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.  www.convatecgroup.com

Enquiries

Bobby Leach, VP Group Corporate Affairs, ConvaTec                    +44 (0)7770 842 226

Kirsty Law, Director Investor Relations                                         +44 (0)7470 909 582

Rebecca Fitchett, Finsbury                                                         +44 (0)207 251 3801

# # #

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGMIJMFTMBBMBJR